Solid Biosciences Inc.

SLDB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$8.02-0.50%

2026-08-03

Financials

Valuation Metrics

Solid Biosciences Inc.'s Market Cap is $790M. At end of 2025 it was $534M. Ranked #2618 of 3,112 in US market (top 84%), #1103 of 1,445 on NASDAQ (top 76%), #205 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 76%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$790M	US#2,618/3,112 Sec#205/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-192M	US—/3,112 Sec—/269
Total Assets	$423M	US#2,806/3,112 Sec#177/269
Net Assets	$374M	US#2,441/3,112 Sec#144/269
Value
P/B	2.11x	US#1,256/3,112 Sec#56/269
FCF Yield	-21.89%	US—/3,112 Sec—/269
Profitability
ROE	-51.26%	US#2,746/3,112 Sec#175/269
ROA	-45.35%	US#2,948/3,112 Sec#204/269
Financial Health
Debt Ratio	13.03%	US#147/3,112 Sec#61/269
Total Debt	$21M	US#2,693/3,112 Sec#178/269
FCF	$-173M	US#2,706/3,112 Sec#203/269
Cash	$298M	US#1,434/3,112 Sec#81/269
Current Ratio	13.10x	US#186/3,112 Sec#63/269
Performance
1Y Return	17.42%	US#1,531/3,112 Sec#168/269
1M Return	-26.01%	US#3,032/3,112 Sec#248/269
From 52W High	-29.96%	US#2,175/3,112 Sec#165/269
1Y MDD	-44.41%	US#2,179/3,112 Sec#165/269
Trading
Volume	760,438 shares	US#1,732/3,112 Sec#167/269
Trading Value	$6M	US#2,591/3,112 Sec#211/269
Per Share
EPS	$-1.84	US—/3,112 Sec—/269
BPS	$1.90	US#2,524/3,112 Sec#181/269